Previous studies have shown that nuclear expression of CXCR4 is associated with better survival than cytomembranous expression, and this might be due to less tumor-promoting effects of the receptor with nuclear localization compared to when the receptor is in the cytomembranous compartment [8, 16]. This evidence concerns the gene CXCR4 and neoplasm.